Key result
DEAP Mapping improves substrate map accuracy over conventional activation mapping by ~0.51 SSIM.
Why the study?
Catheter ablation for non-paroxysmal atrial fibrillation is limited by difficulty identifying abnormal conduction regions, as current mapping relies on excitation-timing annotation that is unreliable under complex conduction.
Does Deep-learning-based Electrode Action Potential Mapping (DEAP Mapping) improve the reconstruction of transmembrane potentials and phase-variance arrhythmogenic substrates from unipolar electrograms compared with conventional activation-time mapping in atrial fibrillation?
Observational (n=12)
Does Deep-learning-based Electrode Action Potential Mapping (DEAP Mapping) improve the reconstruction of transmembrane potentials and phase-variance arrhythmogenic substrates from unipolar electrograms compared with conventional activation-time mapping in atrial fibrillation?
DEAP Mapping enables annotation-free reconstruction of transmembrane potentials and phase-variance substrate maps from standard unipolar catheter electrograms with accuracy comparable to optical mapping, offering a potential tool for individualized substrate characterization in non-paroxysmal atrial fibrillation.
May support annotation-free AF substrate mapping; leaves open clinical utility pending prospective validation.
Catheter ablation for non-paroxysmal atrial fibrillation (non-PAF) remains limited by difficulty in identifying abnormal conduction regions, and current mapping relies on excitation-timing annotation that is unreliable under complex conduction. We developed Deep-learning-based Electrode Action Potential Mapping (DEAP Mapping), which reconstructs membrane potential distributions from unipolar intracardiac electrograms (EGMs) without local activation-time annotation. A convolutional neural network was trained on 13,824 in silico samples from a fibrotic human atrial bidomain model. In ex vivo porcine hearts ( N = 6), DEAP Mapping reconstructed conduction delays and blocks with high similarity to optical mapping (phase-variance-map SSIM 0.87 ± 0.07), outperforming conventional activation maps (0.36 ± 0.14). In a retrospective clinical study ( N = 12 non-PAF patients), the conduction patterns reconstructed by DEAP Mapping partly differed from those of existing methods, and phase-variance analysis revealed spatially continuous conduction heterogeneity with interpatient variability. DEAP Mapping provides annotation-free, optical-comparable substrate visualization from clinical catheter signals, potentially supporting personalized ablation.
No takes yet. Share an insight, caveat, or question.
Seno et al. (2026) conducted an observational in Non-paroxysmal atrial fibrillation (non-PAF) (n=12). Deep-learning-based Electrode Action Potential Mapping (DEAP Mapping) vs. Conventional excitation-timing activation maps (and CARTO Finder / ExTRa Mapping in clinical cases) was evaluated on Structural similarity index measure (SSIM) of phase-variance (PV) maps relative to optical mapping ground truth in ex vivo porcine hearts (MD 0.514, 95% CI 0.415-0.614, p=<0.001). DEAP Mapping improved phase-variance substrate map similarity to optical mapping compared with conventional activation maps (SSIM 0.87 vs 0.36; mean difference 0.514, P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: